RxDoctor Payments Data

Kevin Jackson, MD

Family Medicine · Harrison, ARNPI 1144291907

Payments from drug & device makers

$5,082in general payments, 2019–2025

Across 301 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$701
  • Bayer$486
  • Novo Nordisk$452
  • Amgen$313
  • Sunovion Pharmaceuticals Inc.$266
  • Pfizer$261
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$4,88496%
  • Education$1984%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,082 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$287,879
Medicare patients
411
Services billed
9,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide243$251,538
MounjaroTirzepatide161$175,810
EliquisApixaban131$113,703
JardianceEmpagliflozin110$109,802
Trelegy ElliptaFluticasone/Umeclidin/Vilanter121$90,537
XareltoRivaroxaban110$75,547
Tresiba Flextouch U-200Insulin Degludec67$59,193
FarxigaDapagliflozin Propanediol88$58,861
AdcircaTadalafil11$44,730
TrintellixVortioxetine Hydrobromide112$44,151
AristadaAripiprazole Lauroxil18$43,315
Breztri AerosphereBudesonide/Glycopyr/Formoterol48$37,747
JanuviaSitagliptin Phosphate26$27,185
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog36$27,145
OxycontinOxycodone Hcl22$22,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$452$272,109259 claims
Lilly USA, LLCMounjaro$99$175,810161 claims
PfizerEliquis, Nurtec Odt$261$126,781143 claims
Boehringer IngelheimJardiance, Glyxambi$213$119,339124 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$183$118,334173 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$202$110,065181 claims
Johnson & JohnsonXarelto$93$75,547110 claims
MerckJanuvia, Belsomra$96$37,32771 claims
AbbVieLinzess, Ubrelvy, Savella$701$35,66653 claims
BayerKerendia$486$7,29511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Harrison

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →